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Background: Agonist stimulation of Group I metabotropic glutamate receptors (mGluRs) initiates their coupling to
the heterotrimeric G protein, Gαq/11, resulting in the activation of phospholipase C, the release of Ca2+ from intracellular
stores and the subsequent activation of protein kinase C. However, it is now recognized that mGluR5a also functions as
a receptor for cellular prion protein (PrPC) and β-amyloid peptide (Aβ42) oligomers to facilitate intracellular signaling via
the resulting protein complex. Intracellular mGluR5a signaling is also regulated by its association with a wide variety of
intracellular regulation proteins.
Results: In the present study, we utilized mass spectroscopy to identify calmodulin kinase IIα (CaMKIIα) as a protein that
interacts with the second intracellular loop domain of mGluR5. We show that CaMKIIα interacts with both mGluR1a and
mGluR5a in an agonist-independent manner and is co-immunoprecipitated with mGluR5a from hippocampal mouse
brain. CaMKIIα positively regulates both mGluR1a and mGluR5a endocytosis, but selectively attenuates mGluR5a but not
mGluR1a-stimulated ERK1/2 phosphorylation in a kinase activity-dependent manner. We also find that Aβ42 oligomers
stimulate the association of CaMKIIα with mGluR5a and activate ERK1/2 in an mGluR5a-dependent manner. However,
Aβ42 oligomer-stimulated ERK1/2 phosphorylation is not regulated by mGluR5a/CaMKIIα interactions suggesting that
agonist and Aβ42 oligomers stabilize distinct mGluR5a activation states that are differentially regulated by CaMKIIα. The
expression of both mGluR5a and PrPC together, but not alone resulted in the agonist-stimulated subcellular distribution
of CaMKIIα into cytoplasmic puncta.
Conclusions: Taken together these results indicate that CaMKIIα selectively regulates mGluR1a and mGluR5a ERK1/2
signaling. As mGluR5 and CaMKIIα are involved in learning and memory and Aβ and mGluR5 are implicated in Alzheimer’s
disease, results of these studies could provide insight into potential pharmacological targets for treatment of Alzheimer’s
disease.
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G protein-coupled receptors (GPCRs) comprise the lar-
gest family of transmembrane receptors and function to
transduce extracellular signals into intracellular re-
sponses [1,2]. GPCRs are composed of seven transmem-
brane domains that can be activated by a variety of
stimuli including photons, odorants, hormones, amino
acids, peptides and neurotransmitters [2]. Glutamate, the
major excitatory neurotransmitter in the central nervous
system, signals via the activation of both metabotropic
GPCRs and ionotropic receptors [3-6]. There are eight dif-
ferent GPCRs that respond to glutamate and mediate the
metabotropic glutamate receptor signaling in the brain
[5-7]. These receptors are classified into three subgroups
based on sequence similarity and G protein coupling speci-
ficity. Group I metabotropic glutamate receptors, (mGluR1
and mGluR5), regulate excitatory synaptic signaling re-
sponse via their coupling to the heterotrimeric G protein,
Gαq/11, which upon activation stimulates the activity of the
enzyme phospholipase C to generate the production of
two second messengers, diacylglycerol and inositol 1, 4, 5
trisphosphate. Inositol 1, 4, 5 trisphosphate acts as a ligand
that binds to inositol phosphate receptors localized to the
endoplasmic reticular membrane to release intracellular
Ca2+ stores, in turn Ca2+ functions in combination with di-
acylglycerol to activate protein kinase C [3].
Group I mGluRs serve as molecular scaffold proteins
to regulate both extracellular and intracellular signaling
complexes. Specifically, mGluR5 functions as a receptor
to mediate intracellular Ca2+ signaling and extracellular-
regulated protein kinase (ERK1/2) activation by cellular
prion protein (PrPc) and β42-amyloid (Aβ42) oligomers
[8,9]. PrPc can physically associate with mGluR5, and
binding of Aβ to PrPC generates mGluR5-mediated in-
creases in intracellular Ca2+ concentrations in neurons
[9]. Negative allosteric modulators of mGluR5 weaken the
interaction of PrPc with mGluR5, while positive allosteric
modulators increase this interaction. Silent allosteric mod-
ulators of mGluR5 disrupt Aβ induced interactions of
mGluR5 with PrPc [10], confirming the physical inter-
action of these proteins and suggesting a mechanism by
which PrPc and Aβ can regulate mGluR5 signaling. It is
now recognized that mGluR5 activation by both PrPc and
Aβ42 oligomers also plays an important role in the patho-
physiology associated with Alzheimer’s disease (AD)
[9,11]. Consistent with this concept, mGluR5 selective
antagonists improve the cognitive deficits observed in
AD mouse models and the genetic deletion of mGluR5
results in a reduction in both soluble Aβ42 oligomers
and β-amyloid plaques and results in the amelioration of
cognitive dysfunction observed in APPswePSIΔE9 AD
transgenic mice [11].
Group I mGluRs, in addition to their coupling to Gαq/11
heterotrimeric G proteins, also interact with and scaffold avariety of intracellular signaling proteins that play a pivotal
role in regulating mGluR1/5 signaling, endocytosis, sub-
cellular localization and synaptic activity [3,12]. These pro-
teins include, but are not limited to, Homer, calmodulin,
SIAH-1a, β-arrestin1, casein kinase 1, protein phosphatase
2a, phospholipase D2, RalA, Pyk2, and Fyn [9,13-22]. β-
Arrestin1 has been shown to be involved in mGluR1-
mediated ERK1/2 phosphorylation, as have Pyk2, PKC and
Src [22,23]. Phospholipase D2 and RalA regulate the con-
stitutive endocytosis of Group I mGluRs, as well as a
number of other GPCRs [17,24,25]. In addition, Homer
interactions with Group I mGluRs regulates their G pro-
tein signaling, coupling to the activation of ERK1/2 and
plays a role in Group I mGluR-mediated regulation of
synaptic activity [26-28]. Both mGluR1a and mGluR5a
encode a protein phosphatase 1γ binding motif and pro-
tein phosphatase 2A has been implicated in N-methyl-D-
aspartate (NMDA) receptor-stimulated increases in
mGluR5 activity by promoting the dephosphorylation of
desensitized receptors [21,29].
Emerging studies reveal that Ca2+/calmodulin-dependent
protein kinase IIα (CaMKIIα) can also regulate several
GPCRs. CaMKIIα has been shown to regulate behavioral
responses to cocaine by regulating the D3 dopamine recep-
tor by binding to third intracellular loop of the receptor
to mediate its desensitization [30]. CaMKIIα-dependent
desensitization has also been reported for the D1/D2 het-
erodimer [31] and the Histamine H1 receptor [32]. In con-
trast, CaMKIIα binding to the second intracellular loops of
D1/D2 receptor heteromers increases signaling [33]. More-
over, antagonism of CaMKIIα activity has been shown to
reduce mGluR1 internalization [34,35]. CaMKIIα has been
shown to play a direct role in regulating the desensitization
of mGluR1a inositol 1, 4, 5 trisphosphate signaling by
physically interacting with the C-terminal tail of the recep-
tor [36]. Recently, CaMKIIα has also been shown to inter-
act with the proximal C-terminal tail of mGluR5 in vitro
[37]. In rat striatal neurons, inactive CaMKIIα binds con-
stitutively to mGluR5 and mGluR5- mediated Ca2+ re-
lease results in the dissociation of C-tail bound CaMKIIα
and recruitment to the NMDA receptor where it can
phosphorylate the GluN2B subunit [37].
In the present study, we utilized a cell permeant Tat
peptide from HIV [38] coupled to a peptide encoding the
second intracellular loop (IL2) of mGluR1/5 followed by a
FLAG epitope tag to perform a proteomic screen to iden-
tify neuronal proteins that interact with Group I mGluRs.
As a consequence, we have identified a series of known
Group I-interacting proteins including: protein phosphat-
ase 1γ, protein phosphatase 2A and Gαq11 in the prote-
omic screen, as well as CaMKIIα, β, δ, and γ as novel
proteins that interact with IL2 of mGluR1/5. We find that
CaMKIIα positively regulates the endocytosis of both
mGluR1a and mGluR5a, but has differential effects on
Table 1 Proteins co-precipitated with Tat-mGluR1/5-IL2-FLAG
peptide from mouse neuronal cultures





12934 Dihydropyrimidinase-like 2 23 120 53
65254 Dihydropyrimidinase-like 5 11 77 29.9
15481 Heat shock protein 8 15 32 28.9
51792 α-subunit of regulatory
subunit A, PP2A
8 17 21.6




12332 Ca2+/Calmodulin Kinase IIα 6 16 18.8




22240 Dihydropyrimidinase-like 3 7 16 17.2
233726 Importin 7 16 42 17.0
12995 Casein Kinase 2 α1
polypeptide
4 8 15.6
108058 Ca2+/Calmodulin Kinase IIδ 4 27 15.3








factor 1 alpha 1
4 8 8.2
16565 Kinesin family member 21B 5 8 6.2





13175 Doublecortin-like kinase 1 3 5 5.2
67300 Clathrin heavy chain 5 6 4.1
8120 Adaptor-related protein
complex 3, beta 2
subunit
3 6 3.2
69116 Ubiquitin protein ligase E3
component N-recognin 4
7 11 2.8
22215 Homologous to the E6-AP
(UBE3A)
7 9 2.2
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more, Aβ42 oligomers stimulate mGluR5-mediated ERK1/2
phosphorylation and CaMKIIα association with mGluR5,
but CaMKIIα does not regulate Aβ42 oligomer-stimulated
ERK1/2 phosphorylation. In addition, mGluR5a and PrPC
expression results in the subcellular redistribution of CaM-
KIIα. Taken together our observations indicate that CaM-
KII regulates agonist-stimulated Group I mGluR signaling,
but not Aβ42 oligomer-mediated signaling via mGluR5a.
Results
Identification of novel Group I-interacting proteins by
mass spectroscopy
In order to identify potentially novel mGluR1/5 IL2
interacting proteins, we performed a proteomic screen
using a Tat-tagged mGluR1/5 IL2 peptide conjugated to
a FL-epitope tag to screen by mass spectroscopy pro-
teins in neurons that may bind to mGluR1/5. To do this,
a mixed culture of 107 cortical and striatal neurons was
incubated with the mGluR1/5 Tat peptide (70 μM final
concentration) for 2 hours. We found that a number of
novel and known interacting proteins were identified
(Table 1). The known mGluR1/5 interacting proteins in-
clude Gαq/11, protein phosphatase 1γ catalytic subunit, and
the regulatory subunit of protein phosphatase 2A [19,21].
Amongst the novel mGluR1/5 IL2-interacting proteins
identified were CaMKIIα, β, δ, and γ. As CaMKII antag-
onism was previously reported to antagonize mGluR1a
internalization [34], we examined whether CaMKIIα
interacted with mGluR1a and mGluR5a to regulate either
their signaling or endocytosis.
Co-immunoprecipitation of CaMKIIα with mGluR1a and
mGluR5a
To validate the potential interaction of CaMKIIα with
Group I mGluRs, HEK 293 cells were transfected with ei-
ther FL-epitope-tagged mGluR1a or mGluR5a along with
either GFP or GFP-CaMKIIα. We found that GFP-
CaMKIIα was co-immunoprecipitated with both FL-
mGluR1a and FL-mGluR5a in an agonist-independent
manner (Figures 1A and B). The co-immunoprecipitation
of GFP-CaMKIIα with FL-mGluR1a was not dependent
upon CaMKIIα catalytic activity, as the pretreatment of
HEK 293 cells with 5 μM KN-93 did not affect the extent
of GFP-CaMKIIα co-immunoprecipitated with the recep-
tor (Figure 1C). Endogenous CaMKIIα could be selectively
co-immunoprecipitated with endogenous mGluR5a using
a rabbit polyclonal mGluR5a antibody, but not Rab11 anti-
body, from hippocampal mouse brain lysates (Figure 1D).
Purified mGluR1/5 IL2 loop GST-fusion proteins interact
GFP-CaMKIIα
CaMKIIα interactions with the mGluR1/5 IL2 were
identified by mass spectroscopy following the incubationof neurons with a cell permeant mGluR1/5 IL2 peptide.
To confirm this interaction we purified GST and GST-
IL2 from bacteria and assessed the ability of these con-
structs to co-precipitate either GFP-CaMKIIα or GRK2
(positive control) from HEK 293 cell lysates [39]. We
found that GST-IL2 effectively co-precipitated both
GFP-CaMKIIα and GRK2 (Figure 2A). We then utilized
a series of GST-mGluR1/5 IL2 alanine scanning mutants
that we previously employed to identify IL2 residues re-
quired for GRK2 binding in an attempt to further
Figure 1 Co-immunoprecipitation of GFP-CaMKIIα with FLAG-mGluR1a and FLAG-mGluR5a. Representative immunoblot showing GFP-CaMKIIα
co-immunoprecipitation with either A) FL-mGluR1a or B) FL-mGluR5a from HEK 293 cells transiently transfected as labeled with 3 μg of pcDNA3.1 of either
FL-mGluR1a or FL-mGluR5a along with either 0.5 μg of plasmid cDNA encoding either pEGFP or GFP-CaMKIIα and treated with 50 μM quisqualate for the
times indicated in the Figure. Bar graphs show the quantitative densitometric analysis of GFP-CaMKIIα co-immunoprecipitated with either FL-mGluR1a
or FL-mGluR5a. The data represents the mean±SD of 6 independent experiments. C) Representative immunoblot showing GFP-CaMKIIα co-immunoprecipitation
with FLAG-mGluR5a in HEK 293 cells treated with or without 5 μM KN-93 that were transiently transfected with 2 μg of FL-mGluR5 along with 0.5 μg
of GFP-CaMKIIα. Bar graphs show the quantitative densitometric analysis of GFP-CaMKIIα co-immunoprecipitated with FL-mGluR5a in the absence and
following pretreatment with 5 μM KN-93 for 1 h. The data represents the mean ± SD of 6 independent experiments. D) Shown is a representative
immunoblot of endogenous CaMKII co-immunoprecipitated with endogenous mGluR5. 1 mg of adult CD-1 mouse hippocampal tissue lysate was
incubated with protein G sepharose beads and either polyclonal rabbit anti-Rab11 or anti-mGluR5 antibody. Shown is a representative immunoblot
from 4 independent experiments.
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GFP-CaMKIIα (Figure 2B) [39]. However, we were unable
to discern discrete IL2 residues required for GFP-
CaMKIIα binding (Figure 2B). Moreover, FL-mGluR1b,
that lacks an extended carboxyl-terminal tail and two
mGluR1b mutants defective in GRK2 binding (K691A and
K692A), was still effectively able to co-immunoprecipitate
GFP-CaMKIIα (Figure 2C). Thus, although CaMKIIα in-
teracts with the IL2 of mGluR1/5, there appeared to be no
specific IL2 residues that are essential for CaMKIIα
binding.
CaMKIIα contributes to agonist-stimulated endocytosis of
both mGluR1a and mGluR5
It has previously been reported that the antagonism of
CaMKII activity can negatively regulate the internalization
of mGluR1a and its alternatively spliced variants [34].
Therefore, we examined whether the overexpression ofCaMKIIα would increase the agonist-stimulated endocyto-
sis of either FL-mGluR1a or FL-mGluR5a. We found that
the over-expression of GFP-CaMKIIα promoted the
agonist-stimulated endocytosis of both FL-mGluR1a and
FL-mGluR5a (Figures 3A and B). In agreement with the
previous work of Mundell et al., 2002, the CaMKII antag-
onist KN-93 blocked the CaMKIIα-dependent increase of
FL-mGluR1a endocytosis in GFP-CaMKIIα over-expressing
cells [34] (Figure 3A). Thus, it appears that CaMKIIα con-
tributes to the endocytosis of mGluR1a in a kinase activity-
dependent manner.
Effect of CaMKIIα over-expression on mGluR1a/5a-stimulated
ERK1/2 activation
Group I mGluRs couple to the activation of ERK1/2
phosphorylation via a number of different mechanisms,
that include Gαq/11-mediated activation of Ca
2+ signaling
leading to the activation of both protein kinase C and
Figure 2 Purified GST-fusion proteins encoding the mGluR1/5 IL2 loop domain interact with GFP-CaMKIIα. A) Shown is a representative
immunoblot showing the co-immunoprecipitation of G protein-coupled receptor kinase 2 and GFP-CaMKIIα with a GST mGluR1/5 IL2 domain fusion
protein. 1 μg of GST protein was incubated with 500 μg of HEK293 cell lysates over-expressing either GRK2 or GFP-CaMKIIα. The immunoblots
are representative of 3 independent experiments. B) Upper panel, shows the schematic representation of GST-IL2 fusion protein alanine scanning
mutants previously used to identify the IL2 residues required for GRK2 binding to Group I mGluRs [39]. Middle panel shows a representative
immunoblot showing the co-immunoprecipitation of GFP-CaMKIIα with the GST-IL2 fusion protein alanine scanning mutants and the expression of
the GST fusions. Lower panel shows the densitometric analysis of the relative co-immunoprecipitation of GFP-CaMKIIα with the GST-IL2 fusion protein
alanine scanning mutants compared to the wild-type IL2 GST fusion protein. The data represents the mean ± SD of 3 independent experiments. C)
Representative immunoblots showing GFP-CaMKIIα co-immunoprecipitated FL-mGluR1b and FL-mGluR1b mutants (K691A and K692A) that do not bind
GRK2. Also shown are FL-mGluR1a immunoprecipitates and GFP-CaMKIIα expression in cell lysates. Bar graph shows the relative co-immunoprecipitation of
GFP-CaMKIIα with the FL-mGluR1b and FL-mGluR1b mutants (K691A and K692A). Data shown represents the means ± SD of three independent experiments.
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[22,40]. Therefore, we examined whether over-expression
of either CaMKIIα or an autophosphorylation incompe-
tent CaMKIIα-T286A mutant altered either FL-mGluR1a-
or FL-mGluR5a-stimulated ERK1/2 phosphorylation. We
found that neither GFP-CaMKIIα nor CaMKIIα-T286A
over-expression affected FL-mGluR1a-stimulated ERK1/2
phosphorylation in response to 50 μM quisqualate stimu-
lation for either 5 or 10 min (Figure 4A). In contrast,
CaMKIIα over-expression significantly attenuated FL-
mGluR5a stimulated ERK1/2 phosphorylation in response
to 5 and 10 min treatment with 50 μM quisqualate,
whereas the expression of CaMKIIα-T286A mutant had
no effect on quisqualate stimulated ERK1/2 phosphoryl-
ation in FL-mGluR5a expressing cells (Figure 4B).
Effect of Aβ42 oligomer treatment on mGluR5a CaMKIIα
interactions and ERK1/2 signaling
Aβ42 oligomers were recently shown to signal via
mGluR5a [9]. Therefore, we examined whether Aβ42oligomer-stimulated activation of mGluR5a would alter the
agonist-stimulated association of GFP-CaMKIIα with FL-
mGluR5a. We found that 200 nM Aβ42 oligomer treat-
ment of HEK 293 cells transfected with FL-mGluR5a and
GFP-CaMKIIα resulted in a significant time-dependent
increase in GFP-CaMKIIα co-immunoprecipitated with
FL-mGluR5a (Figure 5), a response we did not observe in
response to receptor agonist stimulation (Figures 1A and
B). Given that CaMKIIα negatively regulated agonist-
stimulated mGluR5a-dependent ERK1/2 phosphorylation,
we examined whether Aβ42 oligomer treatment of
mGluR5a resulted in ERK1/2 phosphorylation and whether
this activation was regulated by CaMKIIα interactions. We
found that treatment of FL-mGluR5a expressing cells with
200 nM Aβ42 oligomers stimulated a significant increase
in ERK1/2 phosphorylation, but that Aβ42 oligomer-
stimulated ERK1/2 phosphorylation via the activation of
FL-mGluR5a was not affected by CaMKIIα overexpression
(Figure 6A). Similar to quisqualate-stimulated mGluR5a
activation of ERK1/2 phosphorylation, Aβ42 oligomer-
Figure 3 CaMKIIα overexpression increases agonist-stimulated mGluR1a and mGluR5 endocytosis. A) Upper blot shows a representative
immunoblot for cell surface biotin-labeled mGluR1a in HEK 293 cells transfected with 3 μg of pcDNA3.1 encoding FL-mGluR1a along with 0.5 μg
of plasmid cDNA encoding either GFP or GFP-CaMKIIα following 50 μM quisqualate treatment following 1 h pre-treatment in the presence and
absence of KN-93. Lower blot shows the total cell lysates (50 μg) for mGluR1a. The bar graph shows the densitometric analysis of biotin-labeled
cell surface mGluR1a immunoblots normalized to total mGluR1a biotinylation. Data represents the mean ± SD of 7 independent experiments. *P < 0.05
versus GFP transfected cells. B) Upper blot shows a representative immunoblot for cell surface biotin-labeled mGluR5a in HEK 293 cells transfected with
3 μg of pcDNA3.1 encoding FL-mGluR5a along with 0.5 μg of plasmid cDNA encoding either GFP or GFP-CaMKIIα following 50 μM quisqualate treatment.
Lower blot shows the total cell lysates (50 μg) for mGluR5a. The bar graph shows the densitometric analysis of biotin-labeled cell surface mGluR1a
immunoblots normalized to total mGluR5a biotinylation. Data represents the mean ± S.E.M. of 4 independent experiments completed in duplicate. *P < 0.05
versus GFP transfected cells, #P < 0.05 versus GFP CaMKIIα control.
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by the pretreatment of HEK 293 cells with 1 mM of the
PKC inhibitor Bisindolymaleimide I (Bis I) (Figure 6B).
Thus, Aβ42 oligomers could stimulate ERK1/2 phosphor-
ylation in an mGluR5a- and PKC-dependent manner that
was not regulated by CaMKIIα, despite the fact that Aβ42
oligomers increased CaMKIIα association with mGluR5a.
Effect of PrPC overexpression on the subcellular
distribution of CaMKIIα
Aβ42 oligomers were previously shown to interact with
PrPC with high-affinity and this complex was recently
shown to utilize mGluR5a as a scaffold to facilitate Aβ42
oligomer-dependent intracellular signaling [9,41,42].
Moreover, Aβ42 oligomers were shown to stimulate the
subcellular redistribution of CaMKII resulting in im-
paired α-amino-3-hydroxy-5-methyl-4-isoxazolepropio-
nic acid (AMPA) receptor trafficking [43]. Therefore, we
assessed whether the co-expression of mGluR5a and
PrPC would alter the subcellular localization of GFP-
CaMKIIα in HEK 293 cells. The expression of mGluR5aand PrPC did not alter the subcellular distribution of GFP
in HEK 293 cells (Figure 7A). In addition, 30 μM quisqua-
late treatment did not affect the diffuse cytosolic distribu-
tion of GFP-CaMKIIα when it was expressed alone in
HEK 293 cells (Figure 7B). Co-expression of either
mGluR5a or PrPC alone with GFP-CaMKIIα did not alter
the subcellular localization of GFP-CaMKIIα in response
to 30 μM quisqualate treatment (Figures 7C and D). How-
ever, co-expression of both mGluR5a and PrPC along with
GFP-CaMKIIα resulted in the subcellular redistribution of
GFP-CaMKIIα in intracellular cytoplasmic puncta in 13%
of transfected HEK 293 cells following 30 μM quisqualate
treatment (Figures 7E and F). Thus, mGluR5a and PrPC
were both required for agonist-stimulated alterations in
the subcellular localization of GFP-CaMKIIα.
Discussion
In the present study, we screened for novel proteins that
may interact with the IL2 domain of mGluR1 and
mGluR5. In doing so, we identified a number of func-
tionally interesting putative Group I mGluR-interacting
Figure 4 Effect of CaMKIIα overexpression on mGluR1a- and mGluR5a- -stimulated ERK1/2 phosphorylation. A) Shown are representative
immunoblots for FL-mGluR1a expression, p-ERK1/2 activity and total-ERK1/2 expression in HEK 293 cells transiently transfected with 3 μg of pcDNA3.1
encoding FLAG-mGluR1a along with 0.5 μg of plasmid cDNA encoding either GFP, GFP-CaMKIIα or GFP-CaMKIIα-T286A in response to 50 μM quisqualate
treatment for 0, 5 and 10 min. Bar graph shows the densitometric analysis of ERK1/2 phosphorylation normalized to both basal and total ERK1/2 protein
expression. Data represents the mean ± SD of five independent experiments. *P < 0.05 versus GFP transfected control cells. B) Shown are representative
immunoblots for, FL-mGluR5a expression, p-ERK1/2 activity and total-ERK1/2 expression in HEK 293 cells transiently transfected with 3 μg of pcDNA3.1
encoding, FL-mGluR5a along with 0.5 μg of plasmid cDNA encoding either GFP, GFP-CaMKIIα or GFP-CaMKIIα-T286A in response to 50 μM quisqualate
treatment for 0, 5 and 10 min. Bar graph shows the densitometric analysis of ERK1/2 phosphorylation normalized to both basal total ERK1/2 protein
expression. Data represents the mean ± SD of five independent experiments. *P < 0.05 versus GFP transfected control cells.
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Group I mGluR-interacting proteins [19,21]. Specifically,
we found that Gαq/11, the catalytic subunit of protein
phosphatase 1γ and the regulatory subunit of protein
phosphatase 2A, known mGluR5-interacting proteins,
associate with the mGluR1/5 IL2 domain. Here, we show
that CaMKIIα also interacted with the mGluR1/5 IL2
domain, in addition to its reported interaction with the
mGluR1a and mGluR5a carboxyl-terminal tail [36,37].
CaMKIIα is known to both interact with and contrib-
ute to the desensitization of ionotropic glutamate recep-
tors, as well as Gαq/11-coupled dopamine D1 and D3
receptors [30,31,44]. CaMKIIα is reported to interact
with mGluR1a via its association with the mGluR1a
carboxyl-terminal tail in a Ca2+-dependent manner and
contributes to the subsequent attenuation of endogenous
mGluR1a signaling in striatal neurons [36]. CaMKIIα has
also been shown to interact with the carboxyl-terminal tail
of mGluR5a in rat striatal neurons in a calcium dependent
manner [37]. These two proteins dissociate upon activa-
tion of mGluR5 calcium and CaMKII subsequently binds
to and phosphorylates the adjacent GluN2B subunit of theNMDA receptor, suggesting a mechanism by which
mGluR5/CaMKIIα interactions could potentially mediate
long-term potentiation [37]. We find here that CaMKIIα
can be co-immunoprecipitated with both mGluR1a and
mGluR5a in an agonist-independent manner and that it
interacts with a GST-fusion protein encoding IL2 of
mGluR1/5. This indicates that both the IL2 and carboxyl-
terminal tail domains play a role in regulating CaMKIIα
interactions with Group I mGluRs. The interaction of
CaMKIIα with mGluR1a is reported to phosphorylate and
desensitize agonist-stimulated mGluR1a signaling in striatal
neurons and CaMKII activity is suggested to regulate G
protein-coupled receptor kinase 2 (GRK2)-mediated
desensitization of mGluR1a [35,36]. However, we previously
found that DHPG-stimulated inositol phosphate signaling
in mouse striatal neurons is mediated predominantly by
mGluR5a [45]. Thus, either rat striatal neurons express
mGluR1a at different levels than those found in mice or the
interaction of CaMKII with mGluR5a in rat striatal neurons
may also contribute the regulation of mGluR5a in these
cultures. This desensitization may also involve CaMKII-
mediated regulation of GRK2-dependent Group I mGluR
Figure 5 Aβ42 oligomers increase CaMKIIα co-immunoprecipitation
with mGluR5a. A) HEK 293 cells were transiently transfected with
2 μg of pcDNA3.1 encoding FLAG-mGluR5a and 0.5 μg of plasmid
cDNA encoding GFP-CaMKIIα. HEK 293 cells were treated with 200
nM of Aβ42 oligomer for 0, 2, 5, 15 and 30 min. B) The bar graph
shows the densitometric analysis of the relative co-immunoprecipitation
of GFP-CaMKIIα with FL-mGluR5a following Aβ42 oligomer treatment
normalized to total mGluR5a protein expression. Data represents the
mean± SD of 5 independent experiments. *p < 0.05 versus untreated cells.
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for regulating mGluR5 signaling in mouse striatal neurons
and both CaMKII and GRK2 bind to the mGluR1/5 IL2
domain [35,39,45].
Previous studies have demonstrated that many regulatory
proteins interact with both the IL2 and carboxyl-terminal
tail domains of mGluR1/5, including heterotrimeric G pro-
tein, GRK2, phospholipase D1, RalA, Arf6 and Pyk2
[3,17,22,39]. Thus, it is not unprecedented that binding to
the intracellular face of an integral membrane protein
would involve multiple intracellular receptor domains.
However, although desirable, it is difficult, if not impos-
sible to distinguish the relative importance of CaMKIIα
interactions with the IL2 or carboxyl-terminal tail do-
mains of mGluR1/5. Furthermore, previous studies iden-
tified interactions between the IL3 of the D3 dopamine
receptor and CaMKII and the carboxyl-terminal tail of
mGluR1a and CaMKII, indicating that both loop and tail
domains of GPCRs may contribute to CaMKII interac-
tions [27,30]. However, both of these studies failed to
examine whether other intracellular domains of the re-
ceptor could also interact with CaMKII and rather only
examined in vitro interactions with GST fusion proteins,
which may have led to the potential misconception that
CaMKII binds to a single discrete domain in both
receptors.We show that CaMKIIα overexpression increases the
agonist-stimulated internalization of both mGluR1a and
mGluR5a and that this is dependent upon the catalytic ac-
tivity of the enzyme as KN-93 treatment blocked
CaMKIIα-dependent enhancement of mGluR1a endocyto-
sis. These results are similar to those previously reported
for the GABAB receptor, another Class C receptor [46].
The antagonism of CaMKIIα also reduces both the heter-
ologous and agonist-stimulated internalization of mGluR1a
and its alternative splice variants [34,35]. Interestingly, the
agonist-stimulated internalization of mGluR1a appears to
be impaired by its extended carboxyl-terminal tail, as the
mGluR1b and mGluR1c splice variants exhibit enhanced
internalization, which is effectively blocked by KN-93 [34].
In contrast, both we and Mundell and colleagues (2002)
find that internalization of mGluR1a in the absence of
CaMKIIα overexpression in HEK 293 cells is not effect-
ively blocked by KN-93 treatment. Thus, although the
C-terminus of mGluR1a contains the consensus site for
CaMKIIα phosphorylation, the extended C-terminus
may impede interactions with IL2, which we find is also
involved in the interaction of CaMKIIα with the recep-
tor. This impediment may be overcome in neurons
where CaMKIIα is an abundantly expressed protein.
We find that the overexpression of CaMKIIα differen-
tially effects the regulation of ERK1/2 phosphorylation in
response to the activation of both mGluR1a and mGluR5a.
Specifically, mGluR1a-stimulated ERK1/2 phosphorylation
is unaffected by the overexpression of wild-type CaMKIIα.
In contrast, over-expression of wild-type CaMKIIα results
in the attenuation of ERK1/2 phosphorylation in response
to agonist stimulation of mGluR5a. Consistent with these
observations, CaMKII is known to affect DHPG-mediated
ERK1/2 phosphorylation in striatal neurons [47]. Specific-
ally, the treatment of striatal neurons with the CAMKII in-
hibitor, KN-62, resulted in attenuation of DHPG-induced
ERK1/2 phosphorylation in the rat striatum [47]. We also
find that the attenuation of mGluR5a-mediated ERK1/2
phosphorylation by CaMKIIα is dependent upon CaMKIIα
activity, as the overexpression of the autophosphorylation-
incompetent CaMKIIα-T286A mutant did not alter
mGluR5a-stimulated ERK1/2 phosphorylation. CaMKIIα
has been previously shown to phosphorylate the carboxyl-
terminal tail at a CaMKII consensus sequence R/K-x-x-S/
T (Thr871) localized within the carboxyl-terminal tail of
mGluR1a [36]. This consensus site is also conserved
within the carboxyl-terminal tail of mGluR5a (Ser860).
mGluR1a also contains three additional putative consen-
sus sites for CaMKII phosphorylation and is phosphory-
lated at a secondary site by CaMKII at Thr945, which is
not conserved in mGluR5a [36]. The mGluR5a carboxyl-
terminal tail encodes an additional seven putative CaMKII
phosphorylation consensus sequences that are not con-
served in mGluR1a (Ser853, Ser879, Ser871, Ser984,
Figure 6 Aβ42 oligomers stimulate ERK1/2 phosphorylation in an mGluR5a and PKC dependent manner that is independent of CaMKIIα
overexpression. A) Shown are representative immunoblots of p-ERK1/2 activity and total ERK1/2 expression in HEK 293 cells transfected with 2 μg of
pcDNA3.1 encoding FLAG-mGluR5a along with either 0.5 μg of plasmid cDNA encoding either GFP or CaMKIIα and treated with 100 nM Aβ42 oligomer
for 5 and 10 min. Bar graph shows the densitometric analysis of ERK1/2 phosphorylation normalized to both basal and total ERK1/2 protein expression.
Data represents the mean ± SD of 4 independent experiments. *P < 0.05 versus non-transfected (NT) cells. B) Shown are representative immunoblots of
p-ERK1/2 activity and total ERK1/2 expression in HEK 293 cells transfected with 2 μg of pcDNA3.1 encoding FLAG-mGluR5a and treated with either
50 μM quisqualate or 100 nM Aβ42 oligomer in either the presence or absence of 1 μM Bis-1. Bar graph shows the densitometric analysis of ERK1/2
phosphorylation normalized to both basal and total ERK1/2 protein expression. Data represents the mean ± SD of 7 independent experiments. *P < 0.05
versus non-transfected (NT) cells.
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phosphorylation-dependent regulation of mGluR1a- and
mGluR5a-mediated ERK1/2 phosphorylation may be the
consequence of mGluR5a phosphorylation at sites not
present in the mGluR1a C-terminal tail.
We and others show that CaMKII can be co-
immunoprecipitated with full length mGluR1a/5a and
GST fusion proteins encoding the IL2 and carboxyl-
terminal tail domains of mGluR1a/5a. However, this
does not necessarily indicate that CaMKII forms a stable
complex with the receptors required to phosphorylate
and desensitize the receptors or regulate their endocyto-
sis and activation of ERK1/2 phosphorylation [27]. It is
entirely possible that CaMKII is activated in response to
Group I mGluR-stimulated Ca2+ release downstream of
G protein activation as opposed to forming a constitu-
tive component of the mGluR1a/5a signaling complex.
Nevertheless, regardless of whether the regulation of
Group I mGluR desensitization, endocytosis and ERK1/2
phosphorylation requires a stable physical interaction
with the receptor, transient receptor interactions and/orthe phosphorylation of downstream regulatory proteins,
CaMKII clearly plays an important role in regulating
Group I mGluR activity.
Recently, it has been reported that mGluR5a functions
as the co-receptor for PrPC and functions as a scaffold/co-
receptor for both PrPC- and Aβ42 oligomer-mediated
intracellular signaling [42,48]. Aβ42 oligomer binding to
mGluR5 stimulates the clustering of mGluR5 and in-
creases Ca2+ signaling [48]. We find here that Aβ42 oligo-
mer treatment of HEK 293 cells increases the association
of CaMKIIα with mGluR5a and activates mGluR5a-
dependent ERK1/2 signaling to an extent that is similar to
agonist stimulation. Despite the fact that Aβ42 oligomer
treatment leads to increased CaMKIIα association with
mGluR5a, unlike what we observe for agonist-stimulated
ERK1/2 phosphorylation, CaMKIIα interactions do not
antagonize Aβ42-stimulated ERK1/2 phosphorylation.
Nevertheless, both agonist- and Aβ42- stimulated ERK1/2
phosphorylation are protein kinase C-dependent suggest-
ing a role for Ca2+ signaling. Thus, although both
mGluR5a agonists activate ERK1/2 phosphorylation via a
Figure 7 Effect of mGluR5a and PrPC expression of GFP-CaMKIIα subcellular localization following agonist stimulation. HEK 293 cells
were transiently transfected with different combinations of GFP-CaMKIIα (0.5 μg), FLAG-mGluR5a (2 μg), PrPC (2 μg) or empty pEGFP (2 μg)
pcDNA3.1 plasmid cDNA. Shown are representative confocal microscopic images of HEK 293 cells transfected with A) pEGFP (control) along with
both FL-mGluR5a and PrPC, B) GFP-CaMKIIα alone (green), C) GFP-CaMKIIα along with FL-mGluR5a (red), D) GFP-CaMKIIα along with PrPC (blue),
and E) GFP-CaMKIIα along with both FL-mGluR5a and PrPC. All transfections were treated with 30 μM quisqualate for 20 min. F) Quantification of
the number of cells exhibiting GFP-CaMKIIα puncta, number of cells imaged is shown in brackets. Data is representative 4 different experiments.
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stabilize mGluR5a activation states that appear to be dif-
ferentially regulated by CaMKIIα.
Aβ42 oligomers have previously been demonstrated to
activate both p38 MAPK and ERK1/2 via their association
with the α7 nicotinic acetylcholine receptor [49]. Further-
more, Aβ42 oligomer-mediated activation of the β2-adren-
ergic receptor results in the β-arrestin-dependent activation
of ERK1/2 and genetic deletion of the β2-adrenergic re-
ceptor ameliorates the pathophysiological deficits associ-
ated with the APPswe/PS1ΔE9 mouse model of AD [50].
In addition, Aβ42 oligomers induce alterations in the sub-
cellular localization of CaMKIIα leading to altered AMPA
receptor trafficking [44]. We find that the co-expression
of both PrPC, an Aβ42 oligomer binding partner and
mGluR5a, the co-receptor for both Aβ42 oligomers and
PrPC [9], results in the redistribution of GFP-CaMKIIα
into intracellular cytoplasmic puncta. The mechanismsregulating CaMKII clustering in HEK 293 cells and neu-
rons is mediated by similar mechanisms [51]. Thus, this
observed change in CaMKIIα distribution in neurons
leading to altered AMPA receptor localization in response
to Aβ42 oligomer treatment of neurons may involve the
association of Aβ42 oligomers and PrPC with mGluR5a.
Conclusions
In summary, we confirm that mGluR5a acts as a binding
partner for CaMKIIα and demonstrate that in addition to
associating with the mGluR5a C-terminal tail, CaMKIIα in-
teracts with the IL2 domain of mGluR5a and mGluR1a
[36]. Moreover, we find that CaMKIIα overexpression facili-
tates the endocytosis of both mGluR1a and mGluR5a in a
manner that is dependent upon the catalytic activity of the
enzyme. In contrast, CaMKIIα selectively regulates agonist-
stimulated mGluR5a-mediated ERK1/2 phosphorylation,
but not Aβ42 oligomer-mediated ERK1/2 phosphorylation.
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mGluR5a and PrPC expression. Taken together these
data suggest that not only does CaMKIIα regulate
mGluR5a activity, but that Aβ42 oligomer signaling via
its association with mGluR5a and PrPC may contribute




Adult CD-1 mice were from Charles River (Wilmington,
MA). Human Embryonic Kidney (HEK293) Cells were
from American Type Culture Collection (Manassas, VA).
Cell culture reagents were from Invitrogen (Burlington,
ON): Minimal Essential Media (MEM), Dulbecco’s
Modified Eagle Medium (DMEM), Fetal Bovine Serum
(FBS) and 0.25% Trypsin-EDTA. OmniPur Bovine Serum
Albumin (BSA) was from VWR (Mississauga, ON). L-
quisqualic acid (quisqualate) and KN-93 were from
Tocris Bioscience (Minneapolis, MN). Biotinylation re-
agents EZ-Link Sulfo-NHS-SS-Biotin and NeutrAvidin
Agarose Resin, as well as Pierce ECL Western Blotting
Substrate and SuperSignal West Dura Chemiluminescent
Substrate were purchased from Thermo Scientific
(Rockford, IL). Myo-[3H] Inositol was purchased from
Perkin Elmer (Waltham, MA). Protein G Sepharose
beads were from GE Healthcare (Oakville, ON). ANTI-
FLAG M2 Affinity Gel was purchased from Sigma-
Aldrich (St. Louis, MO). A DC Protein Assay Kit was
purchased from BioRad Laboratories (Mississauga, ON).
Kodak X-Omat Blue Film was from Fisher Scientific
(Ottawa, ON). Aβ42 peptide was purchased from
American Peptide (Vista, CA, USA). Bisindolymaleimide I
(Bis-1) hydrochloride was purchased from Calbiochem
(San Diego CA, USA). CaMKII (pan), CaMKIIα, Phospho-
p44/42 MAPK, p44/42 MAPK were purchased from Cell
Signaling Technology (Danvers, MA). Rabbit mGluR1a
and mGluR5a antibodies were purchased from Millipore
(Billerica, MA), GFP antibody was purchased from Invitro-
gen (Mississauga, ON) and secondary mouse and rabbit
antibodies were purchased from GE Healthcare (Oakville,
ON) and BioRad (Mississauga, ON), respectively. GFP-
CaMKIIα construct was from Dr. Paul De Koninck (Laval
University, PQ).
Cell culturing and transfection
Human embryonic kidney (HEK) 293 cells were cultured
in MEM with 8% FBS. Cells were plated on 100 mm
dishes and transfected using a modified calcium phos-
phate method [52] with cDNA amounts indicated in the
Figure Legends. For transfection, cDNA was diluted to
450 μL in sterile distilled water, 50 μL 2.5 M CaCl2 added,
500 μL 2X HEPES-buffered saline (0.38 M NaCl, 0.05 M
HEPES, 1.5 mM Na2HPO4, pH 7.05) added drop-wise andmixed gently before transfection mixture was added to
cells. Cells were washed 16–20 hours post transfection
and then allowed to recover in new media before experi-
mentation. For co-immunoprecipitation, cells recovered
for 24 hours. For all other experiments, cells recovered for
6–8 hours and then were reseeded into 6-well dishes and
allowed to recover for 18 hours.
Mass spectroscopy identification of mGluR1/5 interacting
proteins
Neuronal cultures were prepared from cortical and striatal
brain tissue from CD-1 E14.5 mouse embryo brains. Ani-
mal procedures were approved by The University of West-
ern Ontario Animal Care Committee. After dissection, the
tissue was submitted to trypsin digestion followed by cell
dissociation using a fire-polished pasteur pipette. Cells
were plated on poly-L-ornithine coated dishes in neuroba-
sal media supplemented with N2 and B27 supplements,
2 mM of glutamax, 50 μg/ml penicillin, and 50 μg/ml
streptomycin. Cells were incubated at 37°C and 5% CO2
in a humidified incubator and cultured for 12 days in vitro
(DIV) with media replenishment every 4 days as previ-
ously described [45]. Neurons (1 x 107 cells) seeded in
each of three 100 mm dishes were incubated for 60 min
with a 20 μM final concentration of a Tat-mGluR1/5-
FLAG peptide (Ac-YGRKKRRQRRRIARILAGSKKKICTR
KPRFMSDYKDDDDK-NH2) that encoded a cell per-
meant HIV Tat peptide at its amino-terminal end,
followed by the amino acid sequence corresponding to
the conserved second intracellular loop domains of
mGluR1/5 and followed by a FLAG epitope tag. Subse-
quently, neurons were washed 3 times with PBS and solu-
bilized in 1% Triton-X lysis buffer (25 mM HEPES,
pH 7.5, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA
and 1% Triton X-100) containing protease inhibitors
(1 mM AEBSF and 20 μg/mL of both leupeptin and apro-
tinin). Cellular debris was precipitated by centrifugation
at 13,000 g for 30 min at 4°C. Cellular lysates were pre-
cleared by incubation with a 20 μL volume of Protein A
agarose beads for 6 h. Lysates were then incubated with a
40 μL volume of FLAG M2 resin for 4 h and washed 3X
with Lysis buffer and 3 times with 50 mM NH4HCO3
pH 7.8. Subsequently, co-immunoprecipitates were eluted
with 500 mM NH4OH at pH 11 in three 100 μL volumes
and lyophilized to remove NH4OH. The samples were then
resuspended in a 100 μL volume of H2O and subjected to
a second round of lyophilization. Subsequently, samples
were resuspended in a 50 μL volume of NH4HCO3 pH 8.0
and directly digested with sequencing-grade trypsin
(Promega). The resulting peptide mixture was then ana-
lyzed by liquid chromatography-tandem mass spectrom-
etry using a LTQ-XL Linear Ion Trap Mass Spectrometer
(Thermo Scientific). The acquired tandem mass spectra
were searched against a FASTA file containing the human
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SEQUEST running on the Sorcerer platform (Sage-N
Research). The resulting peptide identifications returned
by SEQUEST were filtered and assembled into protein
identifications using peptide and protein prophets (Institute
of Systems Biology, Seattle) as described previously [53].
Immunoblotting
HEK 293 cells were transiently transfected with various
cDNA constructs as described in the Figure Legends.
One day after transfection, cells were starved for 1 hour
in HBSS (1.2 mM KH2PO4, 5 mM NaHCO3, 20 mM
HEPES, 11 mM Glucose, 116 mM NaCl, 4.7 mM KCl,
1.2 mM MgSO4, 2.5 mM CaCl2, pH 7.4) and subse-
quently stimulated as indicated in the Figure Legends.
Cells were washed on ice with cold Phosphate-Buffered
Saline (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, 1.4 mM KH2PO4, pH 7.2) and then lysed on
a rocking platform for 15 minutes at 4°C for using 0.1%
Triton-X 100 lysis buffer (0.025 M HEPES, 300 mM
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton-X)
with added protease inhibitors: 1 mM AEBSF, 10 μg/ml
leupeptin, and 5 μg/ml aprotinin. Lysate was collected and
centrifuged at 15,000 RPM for 15 minutes at 4°C. 250 μg
of each lysate was incubated with FLAG (FL)-agarose
beads (50 μl bead slurry) for 1–2 hours. Beads were
washed three times with cold PBS. Samples were eluted
using 3x SDS sample buffer with 2-mercaptoethanol and
separated by SDS-PAGE and co-immunoprecipitated pro-
teins were detected by Western Blot.
Brain lysate co-immunoprecipitation
The hippocampus was removed from CD-1 Adult Mice
and placed in 0.5% Triton-X 100 lysis buffer with prote-
ase inhibitors. It was homogenized using a polytron and
solubilized for 2 hours at 4°C. Lysate was then centri-
fuged at 15,000 RPM for 15 minutes at 4°C and 1 mg of
protein was incubated with protein G-sepharose with or
without mGluR5 antibody (Millipore, 1.5 μg) to immu-
noprecipitate mGluR5. Samples were eluted using 3x
SDS sample buffer with 2-mercaptoethanol and sepa-
rated by SDS-PAGE. Membranes were immunoblotted
for immunoprecipitated mGluR5 (Millipore, 1:1000) and
co-immunoprecipitated CaMKIIα (Santa Cruz, 1:250).
GST pull down
GST-mGluR1a-IL2 and mutants were cloned into a
pGEX4T1 vector and transformed into E.coli recombin-
ant bacteria [39]. E. coli bacteria were grown at 37°C
with shaking until OD600 was 0.6-1.0. Cultures were
then induced with 1 mM isopropyl 1-thio-β-D-galacto-
pyranoside for 3 hours at 23°C. Cells were pelleted and
lysed in lysis buffer (500 mM NaCl, 0.5% NP-40, 50 mM
Tris pH7.6, 5 mM EDTA, 5 mM EGTA) containingprotease inhibitors (2 mM AEBSF, 50 mg/ml aprotinin,
20 mg/ml leupeptin) and sonicated (3 times for 10 sec-
onds) at 4°C. Insoluble material was pelleted at 15000 g
for 15 minutes at 4°C. 50 μl of Glutathione-Sepharose bead
slurry was incubated overnight with 1 ml of solubilized
protein to purify GST-fusion constructs. Glutathione-
sepharose beads were then washed 3 times in PBS and
500 μg of HEK 293 cell lysates overexpressing GFP-
CaMKIIα was added to the GST-fusion peptide bound to
matrix and rotated for 1 hour at 4°C. Glutathione-
sepharose beads were then washed 6 times in PBS and
eluted with 3X SDS loading buffer containing β-
mercaptoethanol. Samples were subjected to SDS-PAGE
and membranes were immunoblotted with GFP to deter-
mine if GFP-CaMKIIα was pulled down with the GST-
mGluR1a-IL2 peptides as described previously [39].
ERK activation
Twenty-four hours after transfection, cells were reseeded
into 6-well dishes. The following day, cells were starved
in DMEM overnight. On the day of experiment, cells
were starved for an additional hour in HBSS. Cells were
then stimulated at 37°C with either 50 μM quisqualate or
100 nM Aβ42 oligomers as indicated in the Figure Legends.
For experiments using the PKC inhibitor, 1 μM Bis-1 was
added 30 minutes prior to stimulating cells. Cells were sub-
sequently lysed in lysis buffer (25 mM HEPES, 300 mM
NaCl, 1.5 mM MgCl2, 200 μM EDTA, 0.1% Triton-X) con-
taining protease and phosphatase inhibitors (1 mM AEBSF,
25 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mM NaF,
100 μM Protein concentration was determined using a
Bradford protein assay. The lysates were mixed with SDS
loading buffer containing β-mercaptoethanol prior to gel
loading. ERK1/2 phosphorylation was determined by im-
munoblotting for phospho-ERK1/2 and total ERK1/2 and
the ratio was normalized to basal levels.
Biotinylation internalization assay
HEK293 cells were transiently transfected with receptor
(FL-mGluR1a and FL-mGluR5a) and either pEGFP (con-
trol) or GFP-CaMKIIα (3 μg of receptor and 0.5 μg of
GFP constructs). Cells were serum starved for 1 hour in
HBSS for at 37°C on the morning of the experiment.
Cells were washed and incubated on ice for 20 minutes
in HBSS. Plasma membrane proteins were biotinylated
at 4°C with EZ-Link Sulfo-NHS-SS-Biotin in HBSS and
then incubated at 4°C in 100 mM glycine in HBSS for
30 minutes to quench biotinylation. Cells were then
stimulated with 50 μM quisqualate for 0, 5 and 15 mi-
nutes, which allowed the receptor to internalize.
Remaining cell surface biotin was stripped using
100 mM sodium 2-mercaptoethanesulfonate (MesNa) in
TE Buffer (150 mM NaCl, 1 mM EDTA, 20 mM Tris,
pH 8.6) with 0.2% BSA. A control without stimulation or
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total cell surface receptor. Cells were lysed, biotinylated
protein pulled down with NeutrAvidin agarose resin
(50 μL bead slurry), eluted with 3x SDS sample buffer con-
taining 2-Mercaptoethanol, separated by SDS-PAGE and
immunoblotted for mGluR1a and mGluR5a (Millipore,
1:1000). Internalization of the receptor at various time
points with and without GFP-CaMKIIα was compared to
GFP transfected control cells. Results are expressed as per-
cent cell surface internalization. Protocol was modified
slightly for mGluR1a experiments. Following serum starv-
ing, cells were pretreated for 1 hour with or without
1.0 μM KN-93 in HBSS. For stimulation, cells were stimu-
lated with 50 μM quisqualate for 0 and 15 minutes.
Aβ42 oligomer preparation
Lyophilized Aβ42 peptides stored at -80°C were allowed to
equilibrate to room temperature prior to dilution to 1 mM
with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). HFIP was
evaporated in a vacuum centrifuge in order to form Aβ42
peptide films and films were then stored at -80°C. Prior to
use, Aβ42 peptide films were diluted in dimethylsulphox-
ide (DMSO) to 1 mM and sonicated for 10 minutes in a
Branson sonicator. Aβ42 peptides were then subsequently
diluted to 100 μM in ice-cold F-12 cell culture media
(phenol free red), vortexed immediately for 30 seconds,
and incubated at 4°C for 24 hours in order to form Aβ42
oligomers.
Confocal microscopy
Confocal microscopy was performed using a Zeiss LSM-
510 laser scanning microscope equipped with a Zeiss
63X 1.4 numerical aperture oil immersion lens. Live cell
imaging was performed on HEK293 cells in 35 mm
glass-bottomed plates. mGluR5a was labeled with rabbit
anti-FLAG conjugated Zenon Alexa Fluor 647 antibody
and PrPC was labeled with mouse anti-PrPC conjugated
Zenon Alexa Fluor 555 IgG2B antibody. Visualization of
labelled proteins with GFP-CaMKIIα was performed by
triple excitation (488/543/647 nm), emission band pass
from 505–530 (GFP), long pass at 560 (Alexa Fluor 555)
and 660 (Alexa Fluor 647) filter sets. For internalization ex-
periments, mGluR5a was labelled with rabbit anti-FLAG-
conjugated Zenon Alexa Fluor 555 antibody. Visualization
of antibody-labelled receptor with GFP-CaMKIIα was per-
formed by dual excitation (488/543 nm) and emission band
pass from 505–530 (GFP) and long pass at 560 (Alexa
Fluor 555) filter sets. Receptor was stimulated with the
addition of 30 μM quisqualate (final concentration) for
20 minutes.
Statistical analysis
Immunoblots were quantified using Image Lab software.
GraphPad Prism software was used to analyze data forstatistical significance as well as to analyze and fit dose–
response curves. Statistical significance was determined
by either an unpaired two-tailed t-test or by one-way
ANOVA followed by Tukey’s post hoc multiple compari-
son’s test.
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